Turkey: Clinical Trials In Turkey During The Transition Period

Last Updated: 28 October 2010
Article by Okan Gündüz

An original medicinal product should be preceded over various steps before taking an authorization from the competent authorities. In order to achieve this, security and the efficiency of the medicinal product should be tested and several clinical tests should be applied1. These trials, being subject to various criteria and phases, are conducted on volunteers if the results of in-vitro and animal trials (pre-clinical test) are found satisfactory. Trails, depending on the nature of the related research, should either have a scientific objective or made particularly for treatment purposes only and may be divided into phases, being as the prior or after the authorization.

Clinical trials are not just limited to drug-specific researches and explore non-drug type of researches as well. According to the definition provided in the legislation, these are the researches on human beings, with non-industrial advanced medicinal products, non-medicinal standard treatment applications and genetic materials and further include stem cell transplantation, organ and tissue transplantation, medical products and trials for purpose of treatment. Observational studies on medicinal products are regarded out of the scope of the clinical trials and evaluated under a separate legal regulation.

Primary regulations in Turkish law regarding the clinical trials are the provisions of the Constitution on body immunity and Convention for the Protection of Human Rights and Dignity of the Human Being with regard to the Application of Biology and Medicine, which Turkey is a party. Article 90 of the Turkish Criminal Code which stipulates the eligibility requirements of the experiments on human; Regulation on Clinical Trials; Article 13 of the Regulation on Medical Devices; Regulation on Patient Rights and Regulation on Medical Deontology are the other related substantive legislation. Helsinki Declaration of the World Medical Association and EU Directives 2001/20/EC and 2005/28EC are the piece of legislation that is considered as a reference for Turkish law.

Regulation on Clinical Trials2 has the substantive provisions regarding the clinical trials in Turkey among the above-mentioned regulations. Regulation was prepared by the Ministry of Health by taking into consideration the EU Directives. Recently, Turkish Medical Association (TMA) has filed a lawsuit against the Ministry of Health before the Council of State and requested the cancellation and stay of execution of the certain provisions of the Regulation based on the allegation that it contains provisions against the Constitution, Helsinki Declaration and the EU directives.

Motion for stay of execution has been partly granted by the relevant chamber of the Council of State and TMA has appealed this interim decision before the Board of Chambers of the Council of State (BCCS). BCCS has primarily reviewed the procedural aspects of the Regulation without going into the merits and ruled that the provisions regarding the human body immunity which is protected by the Constitution should be regulated by a statute to be enacted by the Parliament and should not be set forth with a regulation which is an administrative act of the Ministry of Health and therefore granted the motion for stay of execution on the regulation provisions as requested by the TMA.

A question mark has occurred on the status of continuing trials and the ones to be conducted in the future due to the stay of execution decision. A judgment, canceling the regulatory action has an automatic outcome, which means that the administration cannot take any action based on that cancelled regulation and otherwise the administrative action would become null. However, an evaluation needs to be made on a case by case basis, whether any vested rights have arisen with the administrative action before the cancellation of the regulation and whether the cancellation and thereafter the implementation in due course has diminished the administrative stability.

Effect of the decision would occur automatically when a stay of execution decision is rendered, same as being for the cancellation of the regulation. Administration would have fulfilled the requirements of stay of execution decision by suspending and not taking any further steps on the pending actions. In that case, what would happen to the status of individual actions instituted in accordance with the regulation before it was cancelled? The rule is that if any vested rights have arisen with that individual action, it would continue to have legal effect. A case by case analysis should be made depending on the nature of each event.

Non-application of the stay of execution could be the case if the implementation of that decision is legally and de facto impossible3. If we make an analysis regarding the stay of execution decision on clinical trials by applying the above mentioned legal principles, it may be argued that there is legal and de facto impossibility in applying the stay of execution decision for the trials that have taken previously permission from the Ethics Board and the Ministry of Health.

However, instead of making a generalization here, it would be wise to give a decision for each specific clinical trial by taking into account the issues such as the nature of clinical trial, the effects of the suspension that it would cause on volunteers in terms of health and in which phase the clinical trial is conducted. Ultimately, it is expected that this legal gap would be temporary and the legislator by virtue of the importance of the subject, would enact the relevant statute soon. It should also be noted that even if the legislator enacts a statute on the subject, concerned parties may still challenge the provisions on clinical trials and may carry the matter to the Constitutional Court and therefore, if a statute is to be prepared, to which extent it would be in parallel to the above mentioned legislation would be vital.

On the other hand, it is noted that the European Commission has a tendency to change the existing directive, taking into consideration the needs of the sector, but it is expressed that such a change is not expected before the end of 2011.


1. This article reflects the legal situation as of the date it is published.

2. Numbered 27089 and published at Offical Gazzette on 23 December 2008.

3. Council of State, 13th Chamber, 29.11.2005 dated.,E:2005/5546, K:2005/5699.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
Related Articles
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions